8.1000
27-11月-24 08:38:45
15 分の遅延
株式
+0.1000
+1.25%
本日の幅
7.9400 - 8.1000
ISIN
BE0974358906
ソース
Cboe
Nyxoah and Vanderbilt University enter exclusive licensing agreement regarding next generation neurostimulation technologies to treat Obstructive Sleep Apnea (OSA)
01 2 2021 23:56:05 提供 Nasdaq GlobeNewswire
Nyxoah announces full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA)
26 1 2021 00:02:09 提供 Nasdaq GlobeNewswire
First US patient implanted in the DREAM pivotal IDE study, with the Genio® system for the treatment of Obstructive Sleep Apnea (OSA)
05 1 2021 00:39:42 提供 Nasdaq GlobeNewswire